Collaboration leverages Absci’s leading generative AI Drug Creation models to design a novel antibody Half-Life Extension (HLE) platform for animal health applicationsVANCOUVER, Wash. and BOSTON, Jan.
Despite glasses-free 3D peaking in 2011 with the release of the Nintendo 3DS, tech companies can't seem to take a hint, with ...